Emergency Medicine Doctors in Lebanon, NH Accepting Medicare

54 Emergency Medicine doctors found. Showing 41 - 54

Johndavid Mazich Storn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Dr., Lebanon, NH 03756 Phone: 603-650-7254

Elisha Paul Dekoning, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: One Medical Center Drive, Dhmc Department Of Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254

Julie R. Voydik, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7000

Ms. Emily J Colomb, PA Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 10 Alice Peck Day Dr, Lebanon, NH 03766 Phone: 603-448-3121

Nicolas Gerald Ellis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000

Susan A Varga, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254

Dr. Norman Alan Paradis, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Dhmc - Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254    Fax: 603-650-4516

Miguel Alberto Reyes-zaragoza, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 720-878-1338

Michael Drake, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000

Charles Henry Herr, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Dartmouth-hitchcock Clinic, 1 Medical Center Drive, Lebanon, NH 03756 Phone: 603-650-7254

Ryan Randy Knapp, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Dhmc Department Of Emergency Medicine, Lebanon, NH 03756 Phone: 603-650-7254    Fax: 603-650-4516

Ms. Alison G Marshall, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7000

Mr. Evan M. Lowy, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7317

Robert Gougelet, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc- Emergency Department, Lebanon, NH 03756 Phone: 603-653-1189

News Archive

Members of Congress will seek business investment in Rwanda

A delegation of five U.S. members of Congress traveling in Africa "pledged to woo the U.S. business community to invest in Rwanda," New Times/allAfrica.com reports. Rep. Gregory Meeks (D-N.Y.), who is leading the delegation, "said that Rwanda has proven to be one of the most favourable places to do business and it would be a major destination for U.S. investors," the publication writes. "I think the U.S. can continue to send individuals here, businessmen especially, that would invest in Rwanda and also help the people of Rwanda. I think this is very important," Meeks said.

Researchers image a biomarker of neurogenesis

Mirjana Maletic-Savatic, M.D., Ph.D, and co-investigators from Stony Brook University Medical Center, Brookhaven National Laboratory and Cold Spring Harbor Laboratory have discovered a way to image a biomarker of neural stem and progenitor cells (NPCs) in the living human brain.

Study finds lower smoke exposure in several public, private settings following smoking bans

Exposure to secondhand smoke has long been associated with negative health effects. A study of secondhand smoke exposure after two smoking bans in Spain, publishing today in Nicotine & Tobacco Research, suggests that overall exposure can be decreased across all settings by comprehensive legislative efforts.

CytRx commences aldoxorubicin plus doxorubicin Phase 1b trial in advanced solid tumors

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 1b clinical trial to determine the maximum tolerated dose and to evaluate preliminary efficacy of aldoxorubicin (formerly INNO-206) administered in combination with the commonly used chemotherapeutic agent doxorubicin in patients with advanced solid tumors who have failed other therapies.

Engaging public in consensus can help eliminate much of the $700 billion of health care spending

In a groundbreaking policy paper released today, the American College of Physicians (ACP) offered more than a dozen principles for engaging the public in a process that it hopes will lead to consensus on conserving and allocating resources based on the best evidence of clinical effectiveness and value.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3(current)